Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excilor vs Amorolfine in Toenail Onychomycosis
NCT03289871Completed
- Sponsor
- Oystershell
- Start
- Jan 2015
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Randomised, single-blind trial in onychomycosis (2 arms), sponsored by Oystershell. Primary endpoint: Evolution of the percentage of healthy surface versus baseline at 168 days. Started Jan 2015; status: completed.
02
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03289871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289871.